Market Cap (In SEK)
29.02 Billion
Revenue (In SEK)
3.51 Billion
Net Income (In SEK)
-3.85 Billion
Avg. Volume
96.1 Thousand
- Currency
- SEK
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 156.0-268.0
- PE
- -
- EPS
- -
- Beta Value
- 1.802
- ISIN
- SE0011205202
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Ms. Bronwyn Brophy O´Connor
- Employee Count
- -
- Website
- https://www.vitrolife.com
- Ipo Date
- 2001-06-28
- Details
- Vitrolife AB (publ), a medical device company, develops, produces, and markets products for assisted reproduction. It provides oocyte retrieval needles; sperm processing; in vitro fertilization media and oil; micromanipulation pipettes; labware; incubators; cryopreservation; and preimplantation genetic testing products. The company also offers EmbryoScope and Primo Vision time-lapse systems; time-lapse dishes; evaluation tools for time-lapse systems; and Octax laser and imaging systems, as well as log and guard systems and wireless sensors. It operates in Europe, the Middle East, and Africa; Asia; Japan and Pacific; and North and South America. The company was formerly known as Scandinavian IVF Science and changed its name to Vitrolife AB (publ) in 1998. Vitrolife AB (publ) was founded in 1994 and is headquartered in Gothenburg, Sweden.
More Stocks
-
QBAKQualstar Corporation
QBAK
-
5288
-
JKLAKSHMIJK Lakshmi Cement Limited
JKLAKSHMI
-
TROOTROOPS, Inc.
TROO
-
PAC
-
DGNOFDIAGNOS Inc.
DGNOF
-
DUSXFDustin Group AB (publ)
DUSXF
-
QNTQFQinetiQ Group plc
QNTQF